GlassScriptPhysician profile
Jason David Chesney
NPI 1407169535
$4,926.79
in general payments reported to CMS, 2019-2025
20 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,969 · 2020: $1,211 · 2021: $182 · 2022: $132 · 2023: $70.09 · 2024: $148 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,834.21 | 2019 | |
| Medtronic USA, INC. | $1,112.19 | 2020 | |
| Acclarent, INC | $290.74 | 2019-2023 | Acclarent Aera |
| Glaxosmithkline, LLC. | $140.56 | 2022-2025 | Nucala |
| Genzyme Corporation | $97.90 | 2020-2022 | |
| Neurent Medical Limited | $87.30 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Kerecis Limited | $45.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Aerin Medical INC. | $42.88 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $41.66 | 2019 | |
| Integra Lifesciences Corporation | $36.21 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Inspire Medical Systems, INC. | $30.42 | 2024 | Inspire |
| Stryker Corporation | $28.01 | 2020 | |
| Acera Surgical, INC. | $24.65 | 2025 | Restrata Wound Matrix |
| Pfizer INC. | $19.56 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $18.78 | 2025 | Neffy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.41 | 2025 | Dupixent |
| Xoran Technologies LLC | $15.71 | 2021 | |
| Alk-Abello, INC | $14.80 | 2022 | |
| Karl Storz Endoscopy-America | $14.46 | 2023 | Image 1 |
| Optinose US, INC. | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Chesney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.